Method for the safe induction of immunity against RSV
AssigneeJanssen Vaccines & Prevention B.V.
InventorsMyra Noorely Widjojoatmodjo, Olivier Godeaux, Kristi Lynn Williams, Benoit Christophe Stephan Callendret, Jerald C. Sadoff
Life of this patent
Estimating the term…
Abstract
Methods of inducing a safe immune response against respiratory syncytial virus (RSV) in a human subject in need thereof, including administering to the subject a composition including recombinant adenovirus including a nucleic acid encoding an RSV Fusion (F) protein including the amino acid sequence of SEQ ID NO: 1, and a pharmaceutically acceptable carrier, in a total dose of from about 1×1010 to about 2×1011 viral particles (vp), are described.
Claims11
A method of inducing a safe immune response against respiratory syncytial virus (RSV) in a human subject in need thereof, comprising administering to the subject a composition comprising recombinant adenovirus comprising nucleic acid encoding an RSV Fusion (F) protein comprising the amino acid sequence of SEQ ID NO:
- 1, and a pharmaceutically acceptable carrier, in a total dose of from about 1×1010 to about 2×1011 viral particles (vp).
Dependencies are inferred from the claim text.